发明公开
EP1448189A2 USE OF BISINDOLMALEIMIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER
审中-公开
使用和BISINDOLMALEIMIDE吉西他滨癌症
- 专利标题： USE OF BISINDOLMALEIMIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER
- 专利标题（中）： 使用和BISINDOLMALEIMIDE吉西他滨癌症
-
申请号： EP02790352.5申请日： 2002-11-11
-
公开(公告)号： EP1448189A2公开(公告)日： 2004-08-25
- 发明人: BREIMER, Lars, Holger , DHINGRA, Kapil , DHINGRA, Urvashi Hooda , RITLAND, Steve
- 申请人： F. HOFFMANN-LA ROCHE AG
- 申请人地址： 124 Grenzacherstrasse 4070 Basel CH
- 专利权人： F. HOFFMANN-LA ROCHE AG
- 当前专利权人： F. HOFFMANN-LA ROCHE AG
- 当前专利权人地址： 124 Grenzacherstrasse 4070 Basel CH
- 代理机构： Schager, Frank, Dr.
- 优先权： US333977P 20011120
- 国际公布： WO2003043632 20030530
- 主分类号： A61K31/404
- IPC分类号： A61K31/404 ; A61K31/7068 ; A61P35/00
摘要：
The present invention relates to the use of a pharmaceutical combination comprising as a active ingredients a) a component consisting of pharmaceutical composition comprising a compound of formula (I) as defined in the description and claims and b) a component consisting of pharmaceutical composition comprising as an active ingredient gemcitabine for the preparation of a medicament for the treatment of patients suffering with cancer.
信息查询
IPC分类:
